These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 26742101)

  • 21. Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications.
    Bah A; Forman-Kay JD
    J Biol Chem; 2016 Mar; 291(13):6696-705. PubMed ID: 26851279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
    Laptenko O; Tong DR; Manfredi J; Prives C
    Trends Biochem Sci; 2016 Dec; 41(12):1022-1034. PubMed ID: 27669647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
    Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
    J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing the dynamics of disorder.
    Fox SJ; Kannan S
    Prog Biophys Mol Biol; 2017 Sep; 128():57-62. PubMed ID: 28554553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.
    Perez RB; Tischer A; Auton M; Whitten ST
    Proteins; 2014 Dec; 82(12):3373-84. PubMed ID: 25244701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of proline to the pre-structuring tendency of transient helical secondary structure elements in intrinsically disordered proteins.
    Lee C; Kalmar L; Xue B; Tompa P; Daughdrill GW; Uversky VN; Han KH
    Biochim Biophys Acta; 2014 Mar; 1840(3):993-1003. PubMed ID: 24211251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
    De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
    J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic folding of two intrinsically disordered proteins: searching for conformational selection.
    Ganguly D; Zhang W; Chen J
    Mol Biosyst; 2012 Jan; 8(1):198-209. PubMed ID: 21766125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronic Polarization at the Interface between the p53 Transactivation Domain and Two Binding Partners.
    Corrigan AN; Lemkul JA
    J Phys Chem B; 2022 Jul; 126(26):4814-4827. PubMed ID: 35749260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of an intrinsically disordered segment in Ets1 shifts conformational sampling toward binding-competent substates.
    Bui JM; Gsponer J
    Structure; 2014 Aug; 22(8):1196-1203. PubMed ID: 25017730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folding and structural polymorphism of p53 C-terminal domain: One peptide with many conformations.
    Kumar A; Kumar P; Kumari S; Uversky VN; Giri R
    Arch Biochem Biophys; 2020 May; 684():108342. PubMed ID: 32184088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain.
    Vise PD; Baral B; Latos AJ; Daughdrill GW
    Nucleic Acids Res; 2005; 33(7):2061-77. PubMed ID: 15824059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
    Okuda M; Nishimura Y
    J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature effects on the hydrodynamic radius of the intrinsically disordered N-terminal region of the p53 protein.
    Langridge TD; Tarver MJ; Whitten ST
    Proteins; 2014 Apr; 82(4):668-78. PubMed ID: 24150971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
    Lum JK; Neuweiler H; Fersht AR
    J Am Chem Soc; 2012 Jan; 134(3):1617-22. PubMed ID: 22176582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.
    Sun X; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX.
    Levy R; Gregory E; Borcherds W; Daughdrill G
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30832340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.